Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
The integration of digital health services is no longer an optional upgrade but a fundamental requirement for modern clinical studies. As drug development costs soar, manufacturers are turning to Decentralized Clinical Trials (DCT) to reduce patient burden and increase diversity in clinical cohorts.
Standardizing data flow via HL7 FHIR and CDISC protocols ensures that information from wearables seamlessly integrates with Electronic Health Records (EHR).
By bringing the trial to the patient’s home, recruitment rates increase by 40% while dropout rates decrease significantly.
AI-driven monitoring systems allow for immediate safety alerts, preventing adverse events before they escalate.
Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. Our roadmap focuses on three pillars:
Operating in North America, Europe, and Asia-Pacific requires a deep understanding of varied regulatory landscapes. We ensure our manufacturers adhere to:
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability.
A1: By streamlining data collection and reducing the need for physical site visits, integration services can cut trial durations by 15-20%, leading to faster market entry.
A2: Yes, our platforms support API-based integration with major Hospital Information Systems (HIS) and Laboratory Information Systems (LIS) through HL7 FHIR standards.
A3: We employ end-to-end encryption, multi-factor authentication, and blockchain-based data logging to ensure that patient data remains confidential and audit-ready.
A4: We provide 24/7 technical support, localized training for site coordinators, and regulatory consulting to ensure compliance with local healthcare laws in over 60 countries.
Trial Medical
